Engineers Gate Manager’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-443
Closed -$4.02K 2101
2023
Q1
$4.02K Hold
443
﹤0.01% 1602
2022
Q4
$5.19K Buy
443
+8
+2% +$141 ﹤0.01% 1637
2022
Q3
$9K Sell
435
-55
-11% -$1.48K ﹤0.01% 1551
2022
Q2
$12K Sell
490
-40
-8% -$1.36K ﹤0.01% 1841
2022
Q1
$26K Buy
+530
New +$26.2K ﹤0.01% 1776
2021
Q3
Sell
-462
Closed -$46K 2051
2021
Q2
$46K Buy
+462
New +$45K ﹤0.01% 1548

Other funds holding VBIV

Engineers Gate Manager's VBIV Position: Q2 2023 in Review

Engineers Gate Manager sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 443 shares — an estimated $4.02K sold.

Engineers Gate Manager first reported a position in VBIV in Q2 2021 and held it in 6 quarters. The position peaked at $46K in Q2 2021. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

  • Engineers Gate Manager reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
  • Engineers Gate Manager sold 443 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023, an estimated $4.02K.
  • Engineers Gate Manager first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2021 and held it in 6 quarters.
  • Engineers Gate Manager's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $46K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on Engineers Gate Manager's 13F filing for Q2 2023, filed 14 Aug 2023.